Acoziborole could change that. The new drug works for both early and advanced stages of the most common form of sleeping ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved to ...

Phase 3 clinical trial data for AD109 is promising, but the sleep apnea pill might not be the revolution sufferers are looking for. Here's why.

Obstructive sleep apnea or OSA affects nearly a billion people across the globe. It robs people of their sleep — they stop breathing sometimes 20 to 50 to 100 times a night and are abruptly awakened.

Apnimed’s star sleep apnea asset has hit the latest landmark on its march down victory road. The Massachusetts biotech reported May 19 that AD109 met the primary endpoint of a phase 3 trial, reducing ...

Millions of older Americans suffering from insomnia regularly use prescription sleep medications, despite the risk of serious side effects-such as falls, broken bones, cognitive impairment and ...

Today is National Napping Day, so after your afternoon snooze, learn a bit about how sleep changes as we age. When you were ...

Quality sleep is critical for people living with epilepsy to avoid triggering seizures. Poor sleep can affect seizures, memory, and more.

WASHINGTON — Jazz Pharmaceuticals lost its bid to overturn the approval of another company’s rival sleep drug when a D.C. federal judge ruled that the FDA did not violate the Orphan Drug Act when ...